title: Survival of patients with breast cancer attending Bristol Cancer Help Centre.
abstract: The Bristol Cancer Help Centre (BCHC) was set up in 1979 to offer various alternative therapies and treatments for patients with cancer. It attracted much public interest and a high demand for its services--and profound medical scepticism. In a study beginning in 1986 of 334 women with breast cancer attending the centre for the first time between June, 1986, and October, 1987, information about the diagnosis was obtained from case notes. Controls were a sample of 461 women with breast cancer attending a specialist cancer hospital or two district general hospitals. The same information was obtained for the control group as for the BCHC group. All patients have been followed up to June, 1988. 85% of patients with breast cancer attending the BCHC were aged under 55 at diagnosis. More than half had experienced recurrence of their disease before entry. For patients metastasis-free at entry, metastasis-free survival in the BCHC group was significantly poorer than in the controls (relapse rate ratio 2.85). Survival in relapsed cases was significantly inferior to that in the control group (hazard ratio 1.81). For cases metastasis-free at entry to the BCHC there was a significant difference in survival between cases and controls, confirming the difference in metastasis-free survival. There was no significant difference in survival or disease-free survival between the cancer hospital controls and other controls.
authors.affiliation: Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK.
authors.forename: F S
authors.initials: FS
authors.lastname: Bagenal
authors.forename: D F
authors.initials: DF
authors.lastname: Easton
authors.forename: E
authors.initials: E
authors.lastname: Harris
authors.forename: C E
authors.initials: CE
authors.lastname: Chilvers
authors.forename: T J
authors.initials: TJ
authors.lastname: McElwain
mesh_terms: D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D001943:Breast Neoplasms / Q000401:mortality* / Q000628:therapy; D000529:Complementary Therapies; D004739:England; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local